Polysubstance Use Is Rewriting the Rules of Addiction Medicine

• By: Dr. Ryan Cole, PsyD Achieve Whole Recovery
• August 14th, 2026
• addiction medicine, Contingency Management, fentanyl, medetomidine, opioid use disorder, polysubstance use, stimulant use disorder, xylazine
• 286    0

Key Takeaways: Fentanyl increasingly contains sedative adulterants like xylazine and medetomidine, plus stimulants, which is complicating standard opioid use disorder treatment protocols. Xylazine's own withdrawal syndrome and its masking of opioid withdrawal signs are pushing providers...

The Hidden Face of Methamphetamine Addiction: Why We Need to Talk About America’s Silent Crisis

• By: Ariann Chelli Desert Hope Treatment Center
• February 18th, 2026
• anhedonia, brain chemistry changes, criminal justice system, medication-assisted treatment, methamphetamine addiction, overdose deaths, stimulant use disorder, treatment gaps
• 2032    0

Methamphetamine addiction doesn’t discriminate. It reaches into suburban homes and rural communities with equal devastation, yet it remains one of the least understood and most stigmatized forms of substance use disorder in America today. While opioids have dominated national headlines and...